Florence Vallelian

6PUBLICATIONS
10CO-AUTHORS
Haematological tumoursPredictive and prognostic markersPacific Peoples theory of change models for healthPsycholinguistics (incl. speech production and comprehension)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2026
An ontogeny-cytokine code determines macrophage response polarity and tumor outcomes.

Dominik J Schaer, Nadja Schulthess-Lutz, Matthias J Peterhans

|Nov 01, 2025
Stress-NRF2 response axis polarizes tumor macrophages and undermines immunotherapy.

Dominik J Schaer, Nadja Schulthess-Lutz, Livio Baselgia

|Jun 28, 2023
Physical Health-Related Quality of Life Improves over Time in Post-COVID-19 Patients: An Exploratory Prospective Study.

Stefan Malesevic, Noriane A Sievi, Dörthe Schmidt

|May 13, 2023
Chest CT Findings after Mild COVID-19 Do Not Explain Persisting Respiratory Symptoms: An Explanatory Study.

Stefan Malesevic, Noriane A Sievi, Jonas Herth

|Jan 02, 2023
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity.

Marc Pfefferlé, Irina L Dubach, Raphael M Buzzi

|Jan 15, 2022
Heme-stress activated NRF2 skews fate trajectories of bone marrow cells from dendritic cells towards red pulp-like macrophages in hemolytic anemia.

Florence Vallelian, Raphael M Buzzi, Marc Pfefferlé

Pageof 1

Frequent Collaborators

3 joint publications

Nadja Schulthess-Lutz

2 joint publications

Noriane A Sievi

2 joint publications

Christian F Clarenbach

1 joint publications

Raphael M Buzzi